2008 Honda Pilot Exl 4wd on 2040-cars

Auto blog

Honda reports $1.9 billion profit in first quarter despite sales lag at home

Ford, General Motors and Chrysler have been living in a world of sunshine and buttercups after their April-through-June financials hit the newswire, and Toyota is doing pretty good as well. Honda? Not so much.
While Japan's third-largest manufacturer saw $1.9 billion in profits, the 5.1-percent jump was lower than expected thanks to a drop in its home-market sales. US sales also took a sting, as Honda hasn't been able to match the SUV and truck demand that are currently permeating the American market, despite an uptick in Accord sales.
Honda's initial forecasts targeted a take of 209.3 billion yen ($2.1 billion at today's rates), and while a $200 million shortfall is nothing to sniff at, we'd hardly take this as Honda being in trouble. And even with the dip, Honda hasn't adjusted its forecast for the fiscal year, which remains at 780 billion yen ($7.9 billion).

Honda favoring turbo over hybrid for US-market Vezel

While Honda gears up to unveil the new Fit to the US market at the Detroit Auto Show next month, back in its home market, the car's crossover cousin is just going on sale. The Vezel was unveiled at the Tokyo Motor Show last month and already has a three-month waiting list in Japan, where Honda projects that 90 percent of customers will opt for the hybrid version. Not so in the United States, however.
When the Vezel reaches American showrooms, there'll be a number of key differences. For starters, it will carry a different name, though Honda isn't saying what that will be. For another, it will be built for North American consumption at Honda's new plant in Mexico, roughly half of whose production capacity is reportedly being allocated to the new crossover. And finally, it'll have a different engine.
In Japan the Vezel is being offered with a 1.5-liter four-cylinder engine, with or without electric assist. Honda won't offer the hybrid version here - at least not initially - but it is preparing to offer a turbo option. Although it has yet to announce US specifications and options, the 1.5-liter turbo four (also unveiled at the Tokyo show) is considered a stronger likelihood than the 1.0- or 2.0-liter versions.

Honda Walking Assist Device begins US testing at Rehabilitation Institute of Chicago

For years, we've been wondering what implications Honda's Asimo robot could have in the real world, and now we're starting to get a sense of that. Honda announced that it will begin its first US clinical studies of the Walking Assist Device at the Rehabilitation Institute of Chicago in an effort to provided improved mobility for people who have suffered a stroke. While the automotive tie-in here is pretty weak, this is the first time we've heard about this device since it was unveiled back in 2008.
Weighing in at six pounds, Honda's device is fitted to the waist and legs of patients to make it easier to walk, and the 22.2-volt lithium-ion battery provides enough electricity for more than an hour of operation. According to Honda's press release, which is posted below, up to 80 percent of the almost 800,000 stroke victims each year (in the US alone) are afflicted with limited mobility, so a medical aid like this could have a big impact in the real world.